You just read:

ITF Pharma Announces FDA Approval Of TIGLUTIK™ (Riluzole) Oral Suspension For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)

News provided by

ITF Pharma

Sep 06, 2018, 06:00 ET